Area of research
Endocrinology, Diabetes and Metabolism · Orthopedics and Sports Medicine
Research interest
Research interests include Diabetes, Cardiovascular Risks, and Lipoproteins, Bone health and osteoporosis research, Liver Disease Diagnosis and Treatment, and Sirtuins and Resveratrol in Medicine.
Factors Associated with Liver Fibrosis in Chinese Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Association Between Triglyceride-Glucose Index and Serum Uric Acid Levels: A Biochemical Study on Anthropometry in Non-Obese Type 2 Diabetes Mellitus Patients
The role of CD36-Fabp4-PPARγ in skeletal muscle involves insulin resistance in intrauterine growth retardation mice with catch-up growth
Exploring the Multi-Tissue Crosstalk Relevant to Insulin Resistance Through Network-Based Analysis
The Relationships Between Glycated Hemoglobin and Bone Turnover Markers in Patients with Type 2 Diabetes but No Diabetic Nephropathy
Adipose Dysfunction in Adulthood Insulin Resistance of Low-Birth Weight Mice: A Proteomics Study
DOAJ (DOAJ: Directory of Open Access Journals) 2022cited by 3position: middle
Blood lipid levels in patients with osteopenia and osteoporosis:a systematic review and meta-analysis
Meta‐analysis of the effect of sodium–glucose cotransporter 2 inhibitors on hepatic fibrosis in patients with type 2 diabetes mellitus complicated with non‐alcoholic fatty liver disease
The relationship between vitamin D status and islet function in patients with type 2 diabetes mellitus
The Predictive Value of Visceral Adiposity Index and Lipid Accumulation Index for Microalbuminuria in Newly Diagnosed Type 2 Diabetes Patients
Correction: TRIM27 contributes to glomerular endothelial cell injury in lupus nephritis by mediating the FoxO1 signaling pathway
Effect of resveratrol on intestinal tight junction proteins and the gut microbiome in high-fat diet-fed insulin resistant mice
<p>Resveratrol Upregulates mmu-miR-363-3p via the PI3K-Akt Pathway to Improve Insulin Resistance Induced by a High-Fat Diet in Mice</p>
Resveratrol improves high-fat diet-induced insulin resistance in mice by downregulating the lncRNA NONMMUT008655.2.
PubMed 2020cited by 27position: middle
The effects of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide 1 receptor agonists on cognitive functions in adults with type 2 diabetes mellitus: a systematic review and meta-analysis
<p>Effects of Glycated Hemoglobin Level on Bone Metabolism Biomarkers in Patients with Type 2 Diabetes Mellitus</p>
Long non-coding RNA expression profiling following treatment with resveratrol to improve insulin resistance
Association of the Triglyceride to High-Density Lipoprotein Ratio andthe Visceral Adiposity Index with Metabolic Syndrome in Diabetic SusceptiblePopulation
<p>Resveratrol reduces liver endoplasmic reticulum stress and improves insulin sensitivity in vivo and in vitro</p>
Regulation of insulin resistance by targeting the insulin‐like growth factor 1 receptor with microRNA‐122‐5p in hepatic cells
The effect of apelin-13 on pancreatic islet beta cell mass and myocardial fatty acid and glucose metabolism of experimental type 2 diabetic rats
The mechanism of GLT-1 mediating cerebral ischemic injury depends on the activation of p38 MAPK
<p>Resveratrol affects hepatic gluconeogenesis via histone deacetylase 4</p>
<p>Difference Analysis Of Related Factors In Macrovascular And Microvascular Complications In Chinese Patients With Type 2 Diabetes Mellitus: A Case-Control Study Protocol</p>
Erratum: Effect of Resveratrol on Blood Lipid Levels in Patients with Type 2 Diabetes: A Systematic Review and Meta‐Analysis
The association between birth weight and the risk of type 2 diabetes mellitus: a systematic review and meta-analysis
Effect of Resveratrol on Blood Lipid Levels in Patients with Type 2 Diabetes: A Systematic Review and Meta‐Analysis
MicroRNA-802 regulates hepatic insulin sensitivity and glucose metabolism.
PubMed 2018cited by 6position: middle
p38 MAPK Participates in the Mediation of GLT-1 Up-regulation During the Induction of Brain Ischemic Tolerance by Cerebral Ischemic Preconditioning